Research Article
The Pattern of Microorganisms and Drug Susceptibility in Pediatric Oncologic Patients with Febrile Neutropenia
Table 2
Characteristics of 563 febrile neutropenia episodes.
| Patient characteristics | Total(n = 563) |
| Median (range) duration of fever prior to admission (days) | 1 (0, 60) | Interval since the last chemotherapy (days) (median, range) | 10 (0, 148) | Therapy preceding infection, n (%) | | Induction | 155 (27.5%) | Maintenance | 68 (12.1%) | Disease status, n (%) | | Remission | 58 (21.7%) | Not remission | 43 (16.1%) | Duration of neutropenia (days) (median, range) | 8 (1, 49) | Duration of fever in days (median, range) | 3 (1, 38) | White blood cell count on admission (cells/mm³) (median, range) | 670 (10, 2, 35, 150) | Absolute neutrophil count on admission (cells/mm³) (median, range) | 70 (0, 9, 522) | Antifungal therapy in the past 6 months | 123 (21.8%) | G-CSF use before a specific cycle | 164 (29.1%) | Steroid in the past 14 days | 226 (40.1%) | Central venous catheter | 226 (40.1%) | Central line | 111 (19.8%) | PICC line | 102 (18.1%) | Chemoport | 10 (1.8%) | Hickmann | 3 (0.5%) |
|
|